Contineum Therapeutics CTNM
NASDAQ CTNM
$8.29 -0.17 (-2.01%)
As of: Oct 21, 2026 · 3:16 PM EDT

Contineum Therapeutics (CTNM) Interest Expenses (2023)

Updated

Contineum Therapeutics (CTNM) posted Interest Expenses of $208,000 for FY2023.

Analysis

Contineum Therapeutics (CTNM) Interest Expenses (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Eli Lilly 1,137.48 Bn 1,106.07 Bn 19.71 Bn -
2 Johnson & Johnson 618.81 Bn 537.34 Bn 17.26 Bn 281.00 Mn
3 AbbVie 502.02 Bn 475.14 Bn 12.70 Bn -
4 Merck 368.25 Bn 322.63 Bn 12.21 Bn -
5 Novartis Ag 297.87 Bn 261.86 Bn 11.24 Bn 462.00 Mn
6 Astrazeneca 260.90 Bn 234.58 Bn 12.86 Bn 435.00 Mn
7 Amgen 236.67 Bn 192.07 Bn 7.24 Bn 673.00 Mn
8 Gilead Sciences 191.16 Bn 165.36 Bn 6.22 Bn 247.00 Mn
9 Pfizer 169.69 Bn 116.34 Bn 10.94 Bn -
10 Contineum Therapeutics 310.61 Mn -617.57 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 116,000.00
Mar 31, 2023 92,000.00
API Access

Contineum Therapeutics Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-expenses&ticker=CTNM&period=max&api_key=YOUR_API_KEY